Literature DB >> 11004695

Frequent nuclear localization of ICAD and cytoplasmic co-expression of caspase-8 and caspase-3 in human lymphomas.

L Xerri1, F Palmerini, E Devilard, T Defrance, R Bouabdallah, J Hassoun, F Birg.   

Abstract

Lymphoma cells often display in vitro resistance to FAS-induced apoptosis, in which caspases act as crucial cell death effectors. Following FAS stimulation, caspase-8 activates caspase-3, which in turn activates the caspase-activated DNAse (CAD) by proteolysis of its inhibitor (ICAD). To investigate the mechanism of FAS resistance, the expression of caspase-8 was analysed by immunohistochemistry, together with that of the substrates caspase-3 and ICAD, in 52 representative samples from non Hodgkin's lymphoma (NHL), 12 from Hodgkin's disease (HD), and eight benign lymphoid tissues. In benign tissues, caspase-8 was co-expressed with caspase-3 in the cytoplasm in germinal centre (GC) cells and was co-expressed with ICAD in the nuclei of the mantle and marginal zone cells. ICAD expression was weak or absent in GC cells. Cytoplasmic staining for both caspase-8 and caspase-3 was present in 11/12 cases of diffuse large cell B-NHL. Caspase-8 positivity was nuclear and cytoplasmic in 9/9 follicular NHLs, in 5/5 mantle cell NHLs and in 6/6 marginal zone NHLs. Five out of six peripheral T-cell NHLs expressed cytoplasmic caspase-8. Ten out of the 12 HD cases lacked significant cytoplasmic staining for caspase-3 and caspase-8 in the majority of Reed-Sternberg cells. All lymphoma cases exhibited predominant nuclear ICAD positivity. Subcellular fractionation analysis of three lymphoma samples and normal mantle zone cells confirmed that ICAD and caspase-8 were at least partly localized in the nucleus. These results show that the profile of caspase-8 expression is correlated with histological lymphoma subtypes; that caspase-8 is co-expressed with caspase-3 in GC cells and their neoplastic counterparts; that ICAD has an immunohistochemical nuclear localization in vivo; and that caspase-8 and ICAD can be co-expressed in the nuclei of mantle zone and marginal zone cells; their unexpected nuclear localization allows a reappraisal of the biochemical cascade of caspase activation. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004695     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH685>3.0.CO;2-M

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Induction of apoptosis in glioma cells by molecules released from activated macrophages.

Authors:  George G Chen; Ying S Chu; Ernest C W Chak; Billy C S Leung; Wai S Poon
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

2.  The regulation of DNAse activities in subcellular compartments of activated thymocytes.

Authors:  Takuya Nagata; Hiroyuki Kishi; Qin Li Liu; Tadashi Matsuda; Tsuneo Imanaka; Kazuhiro Tsukada; Dongchon Kang; Atsushi Muraguchi
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

3.  Constitutive nuclear localization and initial cytoplasmic apoptotic activation of endogenous caspase-3 evidenced by confocal microscopy.

Authors:  Olivier Ramuz; Daniel Isnardon; Elisabeth Devilard; Emmanuelle Charafe-Jauffret; Jacques Hassoun; FranCoise Birg; Luc Xerri
Journal:  Int J Exp Pathol       Date:  2003-04       Impact factor: 1.925

4.  Decreased Expression of Inhibitor of Caspase-Activated DNase (ICAD) in Renal Cell Carcinoma - Tissue Microarray of Human Samples.

Authors:  Retnagowri Rajandram; Azad H A Razack; Keng Lim Ng; Glenda C Gobe
Journal:  J Kidney Cancer VHL       Date:  2016-03-22

Review 5.  Polyoxometalate-based nanocomposites for antitumor and antibacterial applications.

Authors:  Dening Chang; Yanda Li; Yuxuan Chen; Xiaojing Wang; Dejin Zang; Teng Liu
Journal:  Nanoscale Adv       Date:  2022-08-17

6.  c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.

Authors:  Stephan Mathas; Andreas Lietz; Ioannis Anagnostopoulos; Franziska Hummel; Burkhard Wiesner; Martin Janz; Franziska Jundt; Burkhard Hirsch; Korinna Jöhrens-Leder; Hans-Peter Vornlocher; Kurt Bommert; Harald Stein; Bernd Dörken
Journal:  J Exp Med       Date:  2004-04-12       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.